SynthesisJournal of sleep research2026
Obstructive Sleep Apnea in Bronchiectasis: Prevalence, Risk Factors and Clinical Implications-A Systematic Review and Meta-Analysis.
Synthesis in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Risk of Obstructive Sleep Apnea in Patients with Emphysema Versus Bronchiectasis: A Propensity Score-Matched Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Neurocognitive and neurophysiological consequences of sleep-disordered breathing in bronchiectasis: the role of respiratory rehabilitation.Frontiers in rehabilitation sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea (OSA) has been poorly characterised in patients with bronchiectasis despite potential bidirectional clinical impacts. This systematic review and meta-analysis determined the prevalence of OSA confirmed by polysomnography in cystic fibrosis and non-cystic fibrosis bronchiectasis patients. A comprehensive search of MEDLINE, EMBASE and Cochrane databases through September 2025 identified observational studies reporting polysomnography-confirmed OSA prevalence in adult bronchiectasis patients. Five studies encompassing 256 patients met inclusion criteria, with data extracted and quality assessed using the Newcastle-Ottawa Scale. The pooled obstructive sleep apnea prevalence was 50.5% (95% confidence interval: 42.3%-58.9%) with low heterogeneity, ranging from 40.4% to 64.3% in cystic fibrosis patients and 40.8% to 55.8% in non-cystic fibrosis bronchiectasis patients. Traditional risk factors including obesity and excessive daytime sleepiness showed weak associations, with a mean body mass index of 23.8-24.2 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.